Specialty Pharmacy Trends: NADAC Pricing and Aggressive PBM Prior Authorization Tactics and How You Can Respond
By subscribing, you sent consent to receive SMS or MMS messages from The Remedy Group. To opt out of our text messaging program, send the word STOP to 503-753-9029 at any time. View our Terms of Service and Privacy Policy. Msg & Data rates may apply. Message frequency varies.
November 5, 2017
By admin
UPCOMING WEBINAR:
November 7, 2017, 1 p.m. CT/2 p.m. ET
Steven Bennet
Nearly every day, independent specialty pharmacies face industry changes that threaten their businesses. This year, two changes have been especially impacting – the implementation of the NADAC pricing benchmark and enhanced and aggressive prior authorization protocols and policies implemented by PBMs.
Unfortunately, the implementation of the National Average Drug Acquisition Cost (NADAC) benchmark has been devastating to some pharmacies, which are often reimbursed at or below acquisition cost. Similarly, independent pharmacies have witnessed enhanced prior authorization review and processing tactics employed by PBMs, which often drive patients toward PBM-owned pharmacies.
To learn how you can protect your business, join us as Steven L. Bennet, Esq., and Robert R. Granzen, Esq., attorneys at the national boutique healthcare law firm Frier Levitt, demonstrate how your pharmacy can utilize legal avenues to challenge unlawful prior authorization tactics as well as unreasonable Medicaid reimbursement rates.
Robert Granzen
This presentation will help you:
- Understand the origin, implementation, and effects of the NADAC pricing benchmark
- Understand and identify aggressive prior authorization tactics utilized by PBMs
- Interpret related laws and regulations aimed at addressing both NADAC pricing and unlawful prior authorization policies
- Learn what steps your pharmacy should take to combat unreasonable NADAC pricing and egregious prior authorization tactics
